Fingerprint
Dive into the research topics of 'A phase I/II trial of trastuzumab and gefitinib in patients with metastatic breast cancer that overexpresses HER2/neu (ErbB-2)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I/II trial of trastuzumab and gefitinib in patients with metastatic breast cancer that overexpresses HER2/neu (ErbB-2)
Stacy L. Moulder, Carlos L. Arteaga
Research output: Contribution to journal › Article › peer-review
34
Scopus
citations